Aarti Drugs, 524348, AARTIDRUGS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,839.92
28.23
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,392.91
0.19%
3.78

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

9.90
11.71
8.02

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.67
7.97
-6.81

PAT CAGR (%)

10 Years
5 Years
3 Years

9.65
13.13
-15.98

P:E (Median)

8 Years
5 Years
3 Years

20.43
23.17
23.51

P:BV (Average)

8 Years
5 Years
3 Years

4.03
4.56
4.15

EV:EBITDA (Average)

8 Years
5 Years
3 Years

12.55
14.25
15.08

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 492.96 591.63 -16.68% 559.53 696.41 -19.66% 538.21 625.53 -13.96% 577.54 624.83 -7.57%
Expenses 438.74 519.72 -15.58% 490.47 607.89 -19.32% 478.47 556.55 -14.03% 512.12 554.65 -7.67%
EBITDA 54.22 71.91 -24.60% 69.06 88.52 -21.98% 59.74 68.98 -13.40% 65.42 70.18 -6.78%
EBIDTM 11.00% 12.15% 12.34% 12.71% 11.10% 11.03% 11.33% 11.23%
Other Income 0.11 0.65 -83.08% 1.11 0.93 19.35% 1.68 0.97 73.20% 0.74 0.09 722.22%
Interest 7.46 7.77 -3.99% 8.09 8.35 -3.11% 6.75 9.12 -25.99% 7.55 8.27 -8.71%
Depreciation 11.71 11.75 -0.34% 12.34 11.68 5.65% 11.80 11.87 -0.59% 11.78 11.92 -1.17%
PBT 35.16 53.04 -33.71% 49.74 69.42 -28.35% 42.87 48.96 -12.44% 46.83 50.08 -6.49%
Tax 8.25 13.50 -38.89% 13.60 16.25 -16.31% 11.25 12.25 -8.16% 12.25 13.50 -9.26%
PAT 26.91 39.54 -31.94% 36.14 53.17 -32.03% 31.62 36.71 -13.87% 34.58 36.58 -5.47%
PATM 5.46% 6.68% 6.46% 7.63% 5.88% 5.87% 5.99% 5.85%
EPS 2.93 4.30 -31.86% 3.93 5.79 -32.12% 3.44 3.99 -13.78% 3.76 3.98 -5.53%

Description Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var% Sep 23 Sep 22 Var%
Net Sales 555.34 661.11 -16.00% 619.99 742.41 -16.49% 605.94 663.96 -8.74% 641.54 687.72 -6.71%
Expenses 490.38 577.04 -15.02% 534.18 648.87 -17.68% 535.80 593.31 -9.69% 565.09 613.45 -7.88%
EBITDA 64.96 84.07 -22.73% 85.81 93.54 -8.26% 70.14 70.65 -0.72% 76.45 74.27 2.94%
EBIDTM 11.70% 12.72% 13.84% 12.60% 11.58% 10.64% 11.92% 10.80%
Other Income 1.11 0.60 85.00% 1.08 0.87 24.14% 1.67 1.01 65.35% 0.68 0.06 1,033.33%
Interest 8.71 8.54 1.99% 9.13 8.63 5.79% 7.60 9.36 -18.80% 8.25 8.47 -2.60%
Depreciation 13.38 12.60 6.19% 13.58 12.50 8.64% 12.66 12.62 0.32% 12.61 12.66 -0.39%
PBT 43.98 63.53 -30.77% 64.18 73.28 -12.42% 51.55 49.68 3.76% 56.27 53.20 5.77%
Tax 10.71 15.56 -31.17% 16.87 17.10 -1.35% 14.84 13.01 14.07% 16.67 14.46 15.28%
PAT 33.27 47.97 -30.64% 47.31 56.18 -15.79% 36.71 36.67 0.11% 39.60 38.74 2.22%
PATM 5.99% 7.26% 7.63% 7.57% 6.06% 5.52% 6.17% 5.63%
EPS 3.62 5.17 -29.98% 5.15 6.06 -15.02% 3.99 3.96 0.76% 4.31 4.18 3.11%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 2,168.24 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25 1,140.46 1,088.72 1,075.50 1,087.22 971.75 Net Sales Growth -14.58% 10.96% 17.56% 17.12% 12.42% 27.51% 4.75% 1.23% -1.08% 11.88% Cost Of Goods Sold 1,451.04 1,690.45 1,456.26 1,122.09 1,028.03 950.77 686.64 673.19 690.90 717.77 642.52 Gross Profit 717.20 807.52 794.92 792.80 606.89 503.48 453.82 415.53 384.59 369.45 329.23 GP Margin 33.08% 32.33% 35.31% 41.40% 37.12% 34.62% 39.79% 38.17% 35.76% 33.98% 33.88% Total Expenditure 1,919.80 2,211.92 1,930.01 1,510.52 1,386.98 1,251.51 955.32 909.74 899.74 914.93 821.71 Power & Fuel Cost - 153.45 126.05 95.64 101.04 82.14 68.97 56.61 52.64 49.30 47.84 % Of Sales - 6.14% 5.60% 4.99% 6.18% 5.65% 6.05% 5.20% 4.89% 4.53% 4.92% Employee Cost - 64.25 57.17 55.60 52.65 47.23 45.12 42.76 36.93 32.68 28.51 % Of Sales - 2.57% 2.54% 2.90% 3.22% 3.25% 3.96% 3.93% 3.43% 3.01% 2.93% Manufacturing Exp. - 207.43 194.14 155.21 139.77 121.08 108.53 90.77 77.25 73.58 59.39 % Of Sales - 8.30% 8.62% 8.11% 8.55% 8.33% 9.52% 8.34% 7.18% 6.77% 6.11% General & Admin Exp. - 22.94 25.46 25.58 18.53 12.51 10.79 10.39 9.85 10.21 9.73 % Of Sales - 0.92% 1.13% 1.34% 1.13% 0.86% 0.95% 0.95% 0.92% 0.94% 1.00% Selling & Distn. Exp. - 67.67 65.68 52.73 41.55 34.95 31.58 30.35 27.78 28.95 29.27 % Of Sales - 2.71% 2.92% 2.75% 2.54% 2.40% 2.77% 2.79% 2.58% 2.66% 3.01% Miscellaneous Exp. - 5.74 5.24 3.67 5.40 2.83 3.69 5.67 4.38 2.43 29.27 % Of Sales - 0.23% 0.23% 0.19% 0.33% 0.19% 0.32% 0.52% 0.41% 0.22% 0.46% EBITDA 248.44 286.05 321.16 404.37 247.94 202.74 185.14 178.98 175.76 172.29 150.04 EBITDA Margin 11.46% 11.45% 14.27% 21.12% 15.17% 13.94% 16.23% 16.44% 16.34% 15.85% 15.44% Other Income 3.64 2.23 4.77 6.42 1.06 2.51 1.17 3.53 0.00 0.65 0.02 Interest 29.85 36.18 23.05 25.71 35.74 41.00 36.30 38.05 47.34 42.21 37.18 Depreciation 47.63 47.29 47.39 47.60 46.67 40.39 37.80 36.69 35.58 30.66 28.12 PBT 174.60 204.81 255.50 337.49 166.60 123.86 112.21 107.78 92.84 100.06 84.76 Tax 45.35 52.00 60.50 80.00 39.30 40.37 38.80 32.30 26.55 22.47 23.97 Tax Rate 25.97% 25.39% 23.68% 23.69% 22.46% 31.63% 34.58% 29.97% 28.60% 22.46% 28.28% PAT 129.25 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 77.60 60.80 PAT before Minority Interest 129.25 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 77.60 60.80 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.96% 6.12% 8.66% 13.46% 8.30% 6.00% 6.44% 6.93% 6.16% 7.14% 6.26% PAT Growth -22.14% -21.64% -24.33% 89.95% 55.48% 18.87% -2.74% 13.86% -14.57% 27.63% EPS 14.06 16.63 21.22 28.04 14.76 9.50 7.99 8.21 7.21 8.44 6.62

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11
Net Sales 2,422.81 2,716.05 2,488.65 2,154.78 1,806.09 1,560.94 1,243.63 1,195.17 1,139.84 1,096.88 501.05 Net Sales Growth -12.06% 9.14% 15.49% 19.31% 15.71% 25.51% 4.05% 4.85% 3.92% 118.92% Cost Of Goods Sold 1,591.19 1,813.56 1,614.49 1,263.35 1,127.29 1,013.53 737.72 744.43 735.08 724.24 321.34 Gross Profit 831.62 902.50 874.15 891.43 678.79 547.40 505.91 450.75 404.77 372.65 179.71 GP Margin 34.32% 33.23% 35.13% 41.37% 37.58% 35.07% 40.68% 37.71% 35.51% 33.97% 35.87% Total Expenditure 2,125.45 2,406.60 2,156.05 1,714.40 1,540.57 1,350.03 1,041.76 1,004.68 960.02 924.51 431.87 Power & Fuel Cost - 156.10 128.34 98.20 103.83 84.39 71.42 59.42 53.93 49.56 29.07 % Of Sales - 5.75% 5.16% 4.56% 5.75% 5.41% 5.74% 4.97% 4.73% 4.52% 5.80% Employee Cost - 80.37 69.30 65.88 61.35 54.55 52.14 47.95 40.19 33.26 19.93 % Of Sales - 2.96% 2.78% 3.06% 3.40% 3.49% 4.19% 4.01% 3.53% 3.03% 3.98% Manufacturing Exp. - 241.58 230.56 181.41 160.38 142.69 130.01 103.21 87.60 75.53 39.18 % Of Sales - 8.89% 9.26% 8.42% 8.88% 9.14% 10.45% 8.64% 7.69% 6.89% 7.82% General & Admin Exp. - 28.31 30.42 29.03 21.39 14.24 12.22 12.81 10.98 10.48 4.86 % Of Sales - 1.04% 1.22% 1.35% 1.18% 0.91% 0.98% 1.07% 0.96% 0.96% 0.97% Selling & Distn. Exp. - 76.01 73.99 70.99 59.46 37.51 34.00 31.16 27.82 28.99 16.21 % Of Sales - 2.80% 2.97% 3.29% 3.29% 2.40% 2.73% 2.61% 2.44% 2.64% 3.24% Miscellaneous Exp. - 10.67 8.95 5.54 6.88 3.11 4.24 5.71 4.42 2.45 16.21 % Of Sales - 0.39% 0.36% 0.26% 0.38% 0.20% 0.34% 0.48% 0.39% 0.22% 0.25% EBITDA 297.36 309.45 332.60 440.38 265.52 210.91 201.87 190.49 179.82 172.37 69.18 EBITDA Margin 12.27% 11.39% 13.36% 20.44% 14.70% 13.51% 16.23% 15.94% 15.78% 15.71% 13.81% Other Income 4.54 2.19 11.32 4.53 1.48 2.41 1.05 4.00 0.00 0.65 0.16 Interest 33.69 37.14 23.91 26.23 37.42 43.51 38.36 40.02 48.02 42.28 17.12 Depreciation 52.23 50.32 50.05 49.88 48.75 42.56 40.06 38.46 36.53 31.02 19.11 PBT 215.98 224.18 269.96 368.79 180.82 127.26 124.50 116.01 95.27 99.72 33.11 Tax 59.09 57.82 64.96 88.62 43.89 41.27 42.20 34.21 26.55 22.47 9.61 Tax Rate 27.36% 25.79% 24.06% 24.02% 23.69% 31.50% 33.90% 29.49% 27.87% 22.53% 29.02% PAT 156.89 166.31 205.04 280.41 141.40 89.75 82.31 81.80 68.72 77.25 23.50 PAT before Minority Interest 156.87 166.36 205.00 280.40 141.40 89.75 82.31 81.80 68.72 77.25 23.50 Minority Interest -0.02 -0.05 0.04 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.48% 6.12% 8.24% 13.01% 7.83% 5.75% 6.62% 6.84% 6.03% 7.04% 4.69% PAT Growth -12.63% -18.89% -26.88% 98.31% 57.55% 9.04% 0.62% 19.03% -11.04% 228.72% EPS 17.07 18.10 22.31 30.51 15.39 9.77 8.96 8.90 7.48 8.41 2.56

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 1,114.30 972.17 859.61 621.79 518.58 433.17 386.97 350.31 303.70 250.90 Share Capital 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 24.22 12.11 Total Reserves 1,021.70 879.57 766.41 598.49 494.99 409.59 363.11 326.10 279.49 238.80 Non-Current Liabilities 250.20 207.67 255.50 294.42 307.00 294.33 279.97 227.31 198.83 119.16 Secured Loans 153.32 109.76 138.99 167.71 186.69 173.99 173.28 160.64 140.72 76.64 Unsecured Loans 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 10.75 0.00 Long Term Provisions 7.11 7.86 22.12 25.12 12.80 16.87 8.66 1.42 0.29 0.00 Current Liabilities 830.99 854.68 521.89 554.49 547.36 588.74 449.18 477.08 464.40 479.67 Trade Payables 419.01 416.19 293.04 316.37 228.43 239.67 170.30 164.18 150.19 150.18 Other Current Liabilities 76.93 82.85 85.40 81.36 71.15 51.94 47.63 42.24 41.19 44.18 Short Term Borrowings 332.42 353.05 142.18 154.61 246.34 296.24 229.57 257.37 251.27 265.60 Short Term Provisions 2.63 2.59 1.28 2.14 1.43 0.89 1.68 13.28 21.76 19.71 Total Liabilities 2,195.49 2,034.52 1,637.00 1,470.70 1,372.94 1,316.24 1,116.12 1,054.70 966.93 849.73 Net Block 634.48 649.41 630.52 611.57 585.67 563.59 542.32 462.77 431.48 372.53 Gross Block 1,144.14 1,112.42 1,052.68 987.49 920.74 862.31 803.53 690.74 665.09 581.13 Accumulated Depreciation 509.65 463.01 422.16 375.92 335.07 298.72 261.21 227.97 233.61 208.60 Non Current Assets 845.96 761.33 676.88 645.33 637.93 619.59 586.64 512.67 460.19 392.50 Capital Work in Progress 160.75 59.62 15.95 10.96 32.37 27.99 14.13 34.04 13.35 8.32 Non Current Investment 28.62 28.03 24.32 20.38 18.92 17.24 18.42 11.12 11.11 4.62 Long Term Loans & Adv. 22.11 24.26 6.09 2.42 0.97 10.77 11.76 4.74 4.24 7.04 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,349.53 1,273.19 960.13 825.36 735.00 696.65 529.48 542.03 506.74 457.24 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 477.73 488.46 390.38 307.41 227.71 254.10 188.75 167.05 153.36 126.73 Sundry Debtors 801.67 711.64 503.99 464.34 436.90 365.23 278.27 321.19 307.59 276.52 Cash & Bank 2.68 2.21 3.81 3.85 4.85 3.91 4.00 4.50 3.43 4.40 Other Current Assets 67.46 0.70 2.44 2.27 65.56 73.40 58.45 49.28 42.36 49.59 Short Term Loans & Adv. 66.76 70.18 59.52 47.50 59.00 63.19 58.45 49.28 42.36 40.86 Net Current Assets 518.54 418.52 438.23 270.88 187.65 107.92 80.30 64.95 42.34 -22.44 Total Assets 2,195.49 2,034.52 1,637.01 1,470.69 1,372.93 1,316.24 1,116.12 1,054.70 966.93 849.74

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11
Shareholder's Funds 1,192.43 1,036.36 913.42 652.49 543.45 455.43 400.13 357.40 308.15 163.16 Share Capital 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 24.22 12.11 Total Reserves 1,099.83 943.76 820.22 629.19 519.86 431.85 376.27 333.18 283.94 151.05 Non-Current Liabilities 295.75 231.60 257.25 300.82 321.06 312.31 296.59 243.78 211.03 290.20 Secured Loans 196.11 129.93 138.99 171.74 199.64 190.53 187.38 176.66 152.72 204.83 Unsecured Loans 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 10.75 62.65 Long Term Provisions 7.27 9.23 21.67 25.13 12.32 16.87 8.39 1.42 0.29 0.00 Current Liabilities 932.98 940.06 595.36 623.19 590.98 621.68 494.31 501.02 482.76 70.10 Trade Payables 480.27 468.67 329.97 329.55 242.63 258.73 196.97 184.90 166.72 65.30 Other Current Liabilities 87.80 111.33 105.38 132.83 82.94 56.42 51.00 43.80 41.53 1.77 Short Term Borrowings 360.55 356.34 157.21 157.73 263.25 305.64 244.66 258.41 252.43 0.00 Short Term Provisions 4.37 3.71 2.80 3.08 2.16 0.89 1.68 13.91 22.08 3.03 Total Liabilities 2,421.39 2,207.96 1,766.01 1,576.50 1,455.49 1,389.42 1,191.03 1,102.20 1,001.94 523.46 Net Block 676.23 689.93 665.40 643.81 624.86 602.39 581.09 493.42 448.46 247.84 Gross Block 1,204.97 1,169.00 1,101.02 1,030.97 970.09 909.20 848.13 725.47 685.21 393.33 Accumulated Depreciation 528.74 479.06 435.62 387.16 345.22 306.81 267.04 232.05 236.75 145.49 Non Current Assets 929.05 814.59 709.22 672.50 671.20 652.55 619.61 536.97 476.40 263.50 Capital Work in Progress 210.35 76.74 19.26 12.21 32.75 28.45 14.28 34.04 16.06 10.37 Non Current Investment 18.80 19.48 17.30 13.36 12.44 10.76 11.94 4.63 4.63 5.28 Long Term Loans & Adv. 23.67 28.44 7.26 3.12 1.15 10.95 12.30 4.88 7.24 0.00 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,492.35 1,393.37 1,056.80 904.00 784.29 736.86 571.42 565.23 525.54 259.96 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 516.29 525.94 415.00 325.40 246.61 278.21 209.63 178.35 164.20 91.83 Sundry Debtors 864.84 749.90 555.23 488.63 458.54 374.94 296.81 331.69 314.27 121.34 Cash & Bank 8.96 22.33 9.78 7.64 5.55 4.27 4.17 4.82 3.58 5.27 Other Current Assets 102.26 0.70 2.44 6.82 73.58 79.44 60.81 50.37 43.49 41.52 Short Term Loans & Adv. 101.56 94.50 74.35 75.50 67.02 69.23 60.81 50.37 43.49 40.62 Net Current Assets 559.37 453.31 461.44 280.81 193.31 115.19 77.11 64.20 42.78 189.86 Total Assets 2,421.40 2,207.96 1,766.02 1,576.50 1,455.49 1,389.41 1,191.03 1,102.20 1,001.94 523.46

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity 162.28 39.90 154.18 196.15 147.30 61.93 174.41 125.27 106.83 95.43 PBT 204.81 255.50 337.71 174.97 127.62 112.21 107.78 92.84 100.06 84.76 Adjustment 78.43 66.76 65.35 79.82 70.77 71.06 68.20 78.20 68.73 61.31 Changes in Working Capital -66.13 -202.27 -161.11 -21.34 -22.19 -99.42 17.93 -25.75 -47.03 -24.09 Cash after chg. in Working capital 217.11 119.99 241.95 233.46 176.21 83.85 193.91 145.29 121.77 121.98 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -54.83 -80.09 -87.78 -37.32 -28.91 -21.92 -19.51 -20.02 -14.94 -26.56 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -131.14 -125.36 -69.03 -29.35 -59.33 -71.09 -96.29 -87.40 -102.30 -104.67 Net Fixed Assets -132.85 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 -88.99 -97.81 Net Investments -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 -6.49 0.51 Others 2.30 -18.24 5.09 17.45 5.16 0.37 3.89 -41.05 -6.82 -7.37 Cash from Financing Activity -30.54 84.11 -85.28 -167.76 -86.96 9.12 -78.42 -36.79 -5.49 10.76 Net Cash Inflow / Outflow 0.61 -1.35 -0.13 -0.96 1.01 -0.04 -0.31 1.07 -0.97 1.52 Opening Cash & Equivalents 1.49 2.84 2.98 3.94 2.93 2.97 3.28 3.43 4.40 2.88 Closing Cash & Equivalent 2.10 1.49 2.84 2.98 3.94 2.93 2.97 4.50 3.43 4.40

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11
Cash From Operating Activity 134.20 70.41 154.95 250.74 143.09 69.77 174.75 133.29 104.59 20.56 PBT 224.18 269.96 369.01 185.29 131.02 124.50 116.01 95.27 99.72 33.11 Adjustment 85.15 71.19 68.60 86.84 75.20 75.12 71.63 79.30 69.40 38.76 Changes in Working Capital -115.46 -187.35 -185.99 19.49 -33.49 -105.19 8.47 -21.25 -49.58 -40.22 Cash after chg. in Working capital 193.88 153.79 251.63 291.62 172.74 94.44 196.11 153.33 119.53 31.65 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -59.67 -83.38 -96.68 -40.88 -29.64 -24.67 -21.36 -20.03 -14.94 -11.09 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -163.97 -149.64 -71.78 -33.21 -61.67 -73.54 -106.98 -98.79 -107.01 -76.36 Net Fixed Assets -132.85 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 -322.27 -65.29 Net Investments -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 13.50 -3.23 Others -30.53 -42.52 2.34 13.59 2.82 -2.08 -6.80 -52.44 201.76 -7.84 Cash from Financing Activity 16.54 92.03 -81.13 -215.41 -80.07 3.92 -68.23 -33.26 1.46 52.55 Net Cash Inflow / Outflow -13.23 12.80 2.04 2.13 1.35 0.15 -0.45 1.24 -0.95 -3.25 Opening Cash & Equivalents 21.61 8.81 6.77 4.64 3.29 3.15 3.60 3.58 4.53 8.52 Closing Cash & Equivalent 8.38 21.61 8.81 6.77 4.64 3.29 3.15 4.82 3.58 5.27

Financial Ratios

Consolidated /

Standalone

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 120.34 104.99 92.23 66.72 54.98 45.92 40.55 36.16 31.35 25.90 ROA 7.23% 10.62% 16.59% 9.54% 6.49% 6.04% 6.95% 6.56% 8.54% 7.75% ROE 14.65% 21.29% 34.79% 23.79% 18.34% 17.90% 20.47% 20.27% 27.98% 26.52% ROCE 15.38% 20.82% 33.35% 21.29% 17.39% 16.64% 18.03% 18.43% 20.80% 21.07% Fixed Asset Turnover 2.21 2.08 1.88 1.71 1.63 1.39 1.59 1.73 1.88 1.97 Receivable days 110.56 98.55 92.29 100.60 100.66 101.27 92.25 98.01 90.90 85.86 Inventory Days 70.59 71.25 66.50 59.73 60.46 69.69 54.75 49.94 43.59 46.69 Payable days 90.17 88.88 99.12 67.96 68.73 71.92 65.41 62.49 57.39 61.49 Cash Conversion Cycle 90.98 80.91 59.67 92.38 92.40 99.04 81.59 85.46 77.10 71.06 Total Debt/Equity 0.48 0.53 0.38 0.59 0.91 1.19 1.16 1.23 1.43 1.51 Interest Cover 6.66 12.08 14.13 5.90 4.11 4.09 3.83 2.96 3.37 3.28

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 11
Book Value (Rs.) 128.77 111.92 98.01 70.01 57.61 48.28 41.93 36.90 31.81 16.84 ROA 7.19% 10.32% 16.78% 9.33% 6.31% 6.38% 7.13% 6.53% 10.13% 4.99% ROE 14.93% 21.03% 35.81% 23.65% 17.97% 19.24% 21.60% 20.65% 32.78% 15.18% ROCE 15.49% 20.75% 34.52% 21.39% 17.01% 17.31% 18.50% 18.33% 23.93% 13.12% Fixed Asset Turnover 2.29 2.19 2.02 1.81 1.66 1.44 1.64 1.75 2.19 1.45 Receivable days 108.50 95.71 88.41 95.71 97.45 97.10 89.05 95.59 67.25 82.06 Inventory Days 70.03 69.00 62.71 57.80 61.36 70.52 54.97 50.69 39.52 54.05 Payable days 95.49 90.28 95.27 64.68 68.08 73.82 67.66 65.68 45.51 45.97 Cash Conversion Cycle 83.04 74.43 55.85 88.83 90.73 93.79 76.36 80.60 61.26 90.14 Total Debt/Equity 0.51 0.52 0.38 0.58 0.93 1.20 1.20 1.26 1.45 1.64 Interest Cover 7.04 12.29 15.07 5.95 4.01 4.25 3.90 2.98 3.36 2.93

Top Investors:

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Aarti Drugs - Quarterly Results
3rd May 2024, 16:30 PM

Read More
USFDA completes inspection at Baddi facility of Aarti Drugs’ arm
23rd Apr 2024, 12:47 PM

USFDA conducted inspection from April 16, 2024 to April 22, 2024
Read More

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: